Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Proxyphylline is a methylxanthine derivative and an adenosine receptor antagonist (Ki = 130 µM).1 It increases coronary flow in isolated guinea pig perfused heart.2 Proxyphylline reduces systolic and diastolic blood pressure in spontaneously hypertensive rats when administered at a dose of 50 mg/kg twice per day for nine days.3 It reduces the thromboplastin activity of murine trophoblast cells when administered at a dose of 30 µg/animal intraperitoneally.4
WARNING This product is not for human or veterinary use.
1. Adenosine antagonism by purines, pteridines and benzopteridines in human fibroblasts. Biochem. Pharmacol. 30(4), 325-333 (1981).
2. Effects of aminophylline, proxyphylline and a proxyphylline-
3. Synthesis, pharmacological activity and nitric oxide generation by nitrate derivatives of theophylline. J. Pharm. Pharmacol. 60(5), 637-645 (2008).
4. Effect of some drugs on thromboplastin activity in mouse trophoblast cells in vitro and in vivo. Biochem. Pharmacol. 35(20), 3433-3439 (1986).